Sarepta suspends Elevidys use in non-ambulatory Duchenne patients after two liver failure deaths, triggering FDA review and clinical trial pause.
Even though Bitcoin remained constrained due to geopolitical concerns, cheaper alternatives to the apex cryptocurrency enticed investors Sunday night.
Leading cryptocurrencies consolidated on Sunday as the Iran-Israel war kept financial markets on edge.
Chime's strong debut is seen as a positive sign for the U.S. IPO market, which has been sluggish for several years. But that may be changing.
Top mid-cap stocks gain, led by energy companies due to increased oil prices from Middle East conflict. Oklo, Bausch Health, Quantum Computing among top performers.
Top 10 large-cap stocks with biggest gains last week: INSM, CRCL, ORCL, ASTS, SAIL, VG, TEM, CASY, EQNR, HAL. Have you invested in them?
11 large-cap stocks were worst performers last week: SJM, CHWY, IOT, UTHR, CVNA, APP, UAL, GRAB, EIX, LULU, MBLY. Analysts lower price forecasts.